...
首页> 外文期刊>Hematology. >Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab
【24h】

Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab

机译:同时罗米洛司汀,Eltrombopag和强的松可成功治疗因氢化可的松,脾切除术,静脉注射IgG和利妥昔单抗难治的Evans综合征的严重血小板减少症

获取原文
获取原文并翻译 | 示例
           

摘要

A 58-year-old woman presented with rheumatoid arthritis-associated Evans syndrome (simultaneous autoimmune hemolytic anemia and autoimmune thrombocytopenic purpura); she was treated unsuccesfully with steroids, romiplostin, rituximab, immunoglobulin G, and splenectomy. The platelet count responded to the combined use of prednisone, eltrombopag, and romiplostin. It may be more reasonable to use combined treatments than sequential monotherapies.
机译:一名58岁妇女,患有类风湿关节炎相关的伊万斯综合征(同时发生自身免疫性溶血性贫血和自身免疫性血小板减少性紫癜);她未接受类固醇,罗米泊汀,利妥昔单抗,免疫球蛋白G和脾切除术的治疗,但未成功。血小板计数对泼尼松,eltrombopag和romiplostin的联合使用有反应。使用联合治疗可能比顺序单一治疗更为合理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号